| 7th Jun 2019 7:00 am |
RNS |
FDA approval for Nucala self-administration |
| 4th Jun 2019 8:00 am |
RNS |
CHMP positive on GSK's Nucala self-administration |
| 3rd Jun 2019 2:31 pm |
RNS |
Total Voting Rights |
| 24th May 2019 10:54 am |
RNS |
Director/PDMR Shareholding |
| 20th May 2019 1:44 pm |
RNS |
Director/PDMR Shareholding |
| 13th May 2019 5:44 pm |
RNS |
Block listing Interim Review |
| 13th May 2019 4:19 pm |
RNS |
Director/PDMR Shareholding |
| 8th May 2019 6:23 pm |
RNS |
Result of AGM & GM |
| 2nd May 2019 5:07 pm |
RNS |
Trelegy Ellipta asthma study met primary endpoint |
| 1st May 2019 3:11 pm |
RNS |
Director/PDMR Shareholding |
| 1st May 2019 2:32 pm |
RNS |
Total Voting Rights |
| 1st May 2019 12:00 pm |
RNS |
1st Quarter Results |
| 29th Apr 2019 12:00 pm |
RNS |
ViiV submits NDA for HIV monthly 2 drug injectable |
| 26th Apr 2019 4:16 pm |
RNS |
ViiV receives CHMP Positive Opinion for Dovato |
| 16th Apr 2019 5:36 pm |
RNS |
Director/PDMR Shareholding |
| 16th Apr 2019 5:35 pm |
RNS |
Director/PDMR Shareholding |
| 16th Apr 2019 5:23 pm |
RNS |
Director/PDMR Shareholding |
| 16th Apr 2019 5:14 pm |
RNS |
Director/PDMR Shareholding |
| 15th Apr 2019 2:45 pm |
RNS |
Director/PDMR Shareholding |
| 12th Apr 2019 4:47 pm |
RNS |
Director/PDMR Shareholding |
| 12th Apr 2019 4:33 pm |
RNS |
Director/PDMR Shareholding |
| 11th Apr 2019 5:01 pm |
RNS |
Director/PDMR Shareholding |
| 9th Apr 2019 7:00 am |
RNS |
FDA approves ViiV's two-drug HIV regimen, Dovato |
| 2nd Apr 2019 1:00 pm |
RNS |
Publication of AGM and GM Shareholder Documents |
| 1st Apr 2019 4:36 pm |
RNS |
Total Voting Rights |
| 28th Mar 2019 4:15 pm |
RNS |
GSK reporting changes - product sales and IFRS 16 |
| 25th Mar 2019 5:02 pm |
RNS |
Director/PDMR Shareholding |
| 21st Mar 2019 4:00 pm |
RNS |
GSK announces further positive data from DREAMM-1 |
| 19th Mar 2019 5:45 pm |
RNS |
Data from GARNET study evaluating dostarlimab |
| 18th Mar 2019 7:00 am |
RNS |
GSK Annual Report 2018 on Form 20-F |
| 12th Mar 2019 3:19 pm |
RNS |
Director/PDMR Shareholding |
| 12th Mar 2019 1:00 pm |
RNS |
Annual Financial Report |
| 11th Mar 2019 6:24 pm |
RNS |
Director/PDMR Shareholding |
| 8th Mar 2019 7:00 am |
RNS |
ViiV positive ph3 data for long acting injectable |
| 5th Mar 2019 5:20 pm |
RNS |
Director/PDMR Shareholding |
| 1st Mar 2019 10:10 am |
RNS |
Total Voting Rights |
| 22nd Feb 2019 5:30 pm |
RNS |
Director/PDMR Shareholding |
| 22nd Feb 2019 11:21 am |
RNS |
GSK response to SFO Statement |
| 21st Feb 2019 4:37 pm |
RNS |
Director/PDMR Shareholding |
| 21st Feb 2019 4:15 pm |
RNS |
Director/PDMR Shareholding |
